Physician profile
Caitlin Olson
NPI 1871189217
$3,119.85
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,502 · 2022: $1,498 · 2023: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $845.07 | 2021 | |
| Abbvie INC. | $690.83 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $219.90 | 2021-2022 | |
| Glaxosmithkline, LLC. | $192.32 | 2021-2022 | |
| Novo Nordisk INC | $187.24 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $167.41 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $130.82 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $98.72 | 2022 | |
| Intuitive Surgical, INC. | $98.53 | 2023 | Da Vinci Surgical System |
| Abbott Laboratories | $84.59 | 2022 | |
| Amarin Pharma, INC. | $76.99 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $72.80 | 2022 | |
| Novartis Pharmaceuticals Corporation | $52.76 | 2022 | |
| Merck Sharp & Dohme LLC | $42.29 | 2021-2022 | |
| Amgen INC. | $34.62 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $21.03 | 2021 | |
| Lilly USA, LLC | $17.91 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.30 | 2022 | |
| Pfizer INC. | $16.91 | 2022 | |
| Ironwood Pharmaceuticals, INC | $15.79 | 2022 | |
| Fidia Pharma USA INC. | $12.95 | 2021 | |
| Alfasigma USA, INC. | $11.85 | 2021 | |
| Endo Pharmaceuticals INC. | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.